Anna Y. Yamamura
Rio De Janeiro, RJ, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Multi-parameter approach to evaluate the timing of memory status after 17DD-YF primary vaccination.
Journal: PLoS neglected tropical diseases
Published: October 05, 2017
Heparin removal by ecteola-cellulose pre-treatment enables the use of plasma samples for accurate measurement of anti-Yellow fever virus neutralizing antibodies.
Journal: Journal of immunological methods
Published: February 09, 2017
New approaches for the standardization and validation of a real-time qPCR assay using TaqMan probes for quantification of yellow fever virus on clinical samples with high quality parameters.
Journal: Human vaccines & immunotherapeutics
Published: May 27, 2015
An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures.
Journal: Vaccine
Published: September 16, 2014
Immunogenicity and safety of measles-mumps-rubella vaccine delivered by disposable-syringe jet injector in healthy Brazilian infants: a randomized non-inferiority study.
Journal: Contemporary clinical trials
Published: August 07, 2014
Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline.
Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline.
Journal: BMC infectious diseases
Published: April 07, 2014
17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study.
Journal: Human vaccines & immunotherapeutics
Published: February 01, 2013
Evaluation of accuracy and reliability of the plaque reduction neutralization test (micro-PRNT) in detection of yellow fever virus antibodies.
Journal: Biologicals : journal of the International Association of Biological Standardization
Published: June 21, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026